Brief: Glenmark Pharma Q3 Consol Net Profit 3.48 Billion Rupees
14/02/2025 12:55
Feb 14 (Reuters) - Glenmark Pharmaceuticals Ltd
GLEN.NS :
* GLENMARK PHARMA Q3 CONSOL NET PROFIT 3.48 BILLION RUPEES
* GLENMARK PHARMA Q3 CONSOL NET SALES 33.02 BILLION RUPEES
Source text: ID:nBSE5683hc
Further company coverage: GLEN.NS
((reuters.briefs@thomsonreuters.com;))
Recent news on Glenmark Pharmaceuticals
See all newsBrief: Glenmark Pharma Says Unit Launches Ryaltris Nasal Spray In Brazil For Allergic Rhinitis
Brief: Glenmark Pharma US Unit Launches Calcium Gluconate Injection USP In Multiple Vial Sizes
India's Glenmark Pharma gains most in three weeks on US approval for Flonase nasal spray
Brief: Glenmark Pharma Gets U.S. FDA Approval For Fluticasone Propionate Nasal Spray 0.05 Mg/Spray
India's Glenmark Pharmaceuticals falls as brokerage flags softer-than-expected quarter